U
Unity Biotechnology D
D
UBX
1.31000
USD
-0.05
(-3.68%)
مغلق
حجم التداول
467
الربح لكل سهم
0
العائد الربحي
0
P/E
-1
حجم السوق
22,070,385
الأخبار
المقالات
العنوان: Unity Biotechnology
القطاع: Healthcare
الصناعة: Biotechnology
Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities unique to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone primarily produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.